Revision of USP Chapter <541> Titrimetry
Recommendation

20/21 October 2026
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
In the Pharmacopeial Forum, PF 48(5), a revision of USP chapter <541> Titrimetry is being proposed. The proposal is based on the version of the chapter official prior to 2013.
The chapter was previously divided into the following main sections:
- Direct titrations
- Residual titrations
- Complexometric titrations
- Oxidation-reduction (Redox) titrations
- Titrations in nonaqueros solvents
- Indicator and potentiometric endpoint detection
- Blank corrections
- Introduction
- Types of titrations
- Materials and equipment
In addition, besides minor editorial changes, the following updates are mentioned in the briefing notes:
- "Incorporate most of the currently official chapter information into the revised chapter in corresponding sections with the same section titles, if applicable.
- Replace Table 1 and Table 2 with information provided under Types of Titrations and Materials and Equipment.
- Add Automated Titration and Standardization of Titrants to provide current information regarding modern titrimetry processes."
The draft of the revised chapter is available on PF Online. Comments can be submitted until November 30, 2022.
Related GMP News
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination
30.09.2026The Relationship between the BP and the Ph. Eur.
30.09.2026New Japanese Pharmacopoeia Drafts (September 2026) Open for Public Comment
30.09.2026EMA publishes final ICH M13B Guideline and Q&A on Bioequivalence

